Synergism of lorazepam and electroconvulsive therapy in the treatment of catatonia

Georgios Petrides, Krishna M. Divadeenam, George Bush, Andrew Francis

Research output: Contribution to journalArticle

85 Citations (Scopus)

Abstract

Electroconvulsive therapy (ECT) and lorazepam are effective treatments for catatonia. ECT combined with benzodiazepines has been associated with reduced efficacy and efficiency and therefore is not recommended in the routine practice of ECT. We report 5 prospectively identified cases of catatonia treated either sequentially or concurrently with lorazepam and ECT. In each case, the combination of lorazepam with ECT was superior to monotherapy. This apparent synergism, its possible mechanisms, and its implications for treating catatonia are discussed.

Original languageEnglish (US)
Pages (from-to)375-381
Number of pages7
JournalBiological Psychiatry
Volume42
Issue number5
DOIs
StatePublished - Sep 1 1997

Fingerprint

Catatonia
Lorazepam
Electroconvulsive Therapy
Benzodiazepines

All Science Journal Classification (ASJC) codes

  • Biological Psychiatry

Cite this

Petrides, Georgios ; Divadeenam, Krishna M. ; Bush, George ; Francis, Andrew. / Synergism of lorazepam and electroconvulsive therapy in the treatment of catatonia. In: Biological Psychiatry. 1997 ; Vol. 42, No. 5. pp. 375-381.
@article{d9bec25430a84e0fb839bd791ce9c6d0,
title = "Synergism of lorazepam and electroconvulsive therapy in the treatment of catatonia",
abstract = "Electroconvulsive therapy (ECT) and lorazepam are effective treatments for catatonia. ECT combined with benzodiazepines has been associated with reduced efficacy and efficiency and therefore is not recommended in the routine practice of ECT. We report 5 prospectively identified cases of catatonia treated either sequentially or concurrently with lorazepam and ECT. In each case, the combination of lorazepam with ECT was superior to monotherapy. This apparent synergism, its possible mechanisms, and its implications for treating catatonia are discussed.",
author = "Georgios Petrides and Divadeenam, {Krishna M.} and George Bush and Andrew Francis",
year = "1997",
month = "9",
day = "1",
doi = "10.1016/S0006-3223(96)00378-2",
language = "English (US)",
volume = "42",
pages = "375--381",
journal = "Biological Psychiatry",
issn = "0006-3223",
publisher = "Elsevier USA",
number = "5",

}

Synergism of lorazepam and electroconvulsive therapy in the treatment of catatonia. / Petrides, Georgios; Divadeenam, Krishna M.; Bush, George; Francis, Andrew.

In: Biological Psychiatry, Vol. 42, No. 5, 01.09.1997, p. 375-381.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Synergism of lorazepam and electroconvulsive therapy in the treatment of catatonia

AU - Petrides, Georgios

AU - Divadeenam, Krishna M.

AU - Bush, George

AU - Francis, Andrew

PY - 1997/9/1

Y1 - 1997/9/1

N2 - Electroconvulsive therapy (ECT) and lorazepam are effective treatments for catatonia. ECT combined with benzodiazepines has been associated with reduced efficacy and efficiency and therefore is not recommended in the routine practice of ECT. We report 5 prospectively identified cases of catatonia treated either sequentially or concurrently with lorazepam and ECT. In each case, the combination of lorazepam with ECT was superior to monotherapy. This apparent synergism, its possible mechanisms, and its implications for treating catatonia are discussed.

AB - Electroconvulsive therapy (ECT) and lorazepam are effective treatments for catatonia. ECT combined with benzodiazepines has been associated with reduced efficacy and efficiency and therefore is not recommended in the routine practice of ECT. We report 5 prospectively identified cases of catatonia treated either sequentially or concurrently with lorazepam and ECT. In each case, the combination of lorazepam with ECT was superior to monotherapy. This apparent synergism, its possible mechanisms, and its implications for treating catatonia are discussed.

UR - http://www.scopus.com/inward/record.url?scp=0030800760&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030800760&partnerID=8YFLogxK

U2 - 10.1016/S0006-3223(96)00378-2

DO - 10.1016/S0006-3223(96)00378-2

M3 - Article

VL - 42

SP - 375

EP - 381

JO - Biological Psychiatry

JF - Biological Psychiatry

SN - 0006-3223

IS - 5

ER -